
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings Inc. demonstrated a strong financial performance with a 31% year-over-year growth in surgical revenue, reaching $177 million, which surpassed consensus expectations. The company also reported an improved adjusted operating margin of (5.5%), an increase of 1,150 basis points year-over-year, reflecting operational efficiency and growth potential. Additionally, the adjusted gross margin of 70.1% exceeded market expectations, indicating a favorable trajectory in profitability metrics.
Bears say
Alphatec Holdings faces significant challenges, primarily related to its projected revenue growth in the U.S., which is anticipated to be lower than expected, leading to concerns over free cash flow generation. Despite positive incremental margins of 41% and a history of successful cost management, the outlook for sequential revenue growth appears to be decelerating, with a projected increase of only 10% from Q3 to Q4 2025 compared to 14% from Q2 to Q3 2025. Additionally, the company is exposed to various risks, including poor sales execution, competition in the spine market, and potential disruptions from external factors such as the COVID-19 pandemic, all of which could adversely affect its financial performance.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares